Literature DB >> 20169350

Comparison of the erectile function in male patients with rectal cancer treated by preoperative radiotherapy followed by surgery and surgery alone.

Phil Hyun Song1, Sang Mo Yun, Jae Hwang Kim, Ki Hak Moon.   

Abstract

PURPOSE: This study evaluates the erectile function of male patients treated by preoperative radiotherapy followed by surgery and surgery alone for locally advanced rectal cancer.
METHODS: A total of 112 men treated by total mesorectal excision with autonomic nerve preservation were included. Seventy-three patients were treated by preoperative radiotherapy followed by surgery (RTS group), and 39 were treated by surgery alone (surgery group). Patients filled out the five-item version of the international index of erectile function (IIEF-5) questionnaire at least 6 months after initial erectile function assessment. We analyzed the impact of age, surgery type, location, and size of tumor on erectile function.
RESULTS: Total score was decreased significantly at follow-up compared to initial assessment in both RTS and surgery group (20.31 +/- 4.39 vs. 11.52 +/- 4.83, P = 0.012; 19.86 +/- 4.61 vs. 14.07 +/- 6.37, P = 0.031, respectively). Score difference was statistically higher in RTS group compared with surgery group (P = 0.028). In terms of surgery type for RTS group, score difference was statistically higher in the patients with abdominoperineal resection (APR) compared with those with lower anterior resection (P = 0.023). In comparison of score difference according to tumor location, difference was statistically higher in the patients with lower rectal cancer compared with those with upper rectal cancer (P = 0.017).
CONCLUSION: The erectile functions of patients treated by preoperative radiotherapy followed by surgery are more affected than that of patients treated by surgery alone in locally advanced rectal cancer. Also APR and lower rectal cancer were significantly associated with erectile dysfunction in the patients treated by preoperative radiotherapy followed by surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20169350     DOI: 10.1007/s00384-010-0879-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

Review 1.  Aggressive multimodality treatment for locally advanced irresectable rectal cancer.

Authors:  R Farouk; H Nelson; L L Gunderson
Journal:  Br J Surg       Date:  1997-06       Impact factor: 6.939

2.  Indication and benefit of pelvic sidewall dissection for rectal cancer.

Authors:  Kenichi Sugihara; Hirotoshi Kobayashi; Tomoyuki Kato; Takeo Mori; Hidetaka Mochizuki; Shingo Kameoka; Kazuo Shirouzu; Tetsuichiro Muto
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

3.  Preservation of urine voiding and sexual function after rectal cancer surgery.

Authors:  K Hojo; A M Vernava; K Sugihara; K Katumata
Journal:  Dis Colon Rectum       Date:  1991-07       Impact factor: 4.585

4.  Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.

Authors:  C A Maurer; K Z'Graggen; P Renzulli; M K Schilling; P Netzer; M W Büchler
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

5.  Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.

Authors:  Corrie A M Marijnen; Cornelis J H van de Velde; Hein Putter; Mandy van den Brink; Cornelis P Maas; Hendrik Martijn; Harm J Rutten; Theo Wiggers; Elma Klein Kranenbarg; Jan-Willem H Leer; Anne M Stiggelbout
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

6.  Late adverse effects of short-course preoperative radiotherapy in rectal cancer.

Authors:  J Pollack; T Holm; B Cedermark; D Altman; B Holmström; B Glimelius; A Mellgren
Journal:  Br J Surg       Date:  2006-12       Impact factor: 6.939

7.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

8.  Quality of life in rectal cancer patients: a four-year prospective study.

Authors:  Jutta Engel; Jacqueline Kerr; Anne Schlesinger-Raab; Renate Eckel; Hansjörg Sauer; Dieter Hölzel
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

9.  Bladder and erectile dysfunction before and after rectal surgery for cancer.

Authors:  J Leveckis; N R Boucher; B T Parys; M W Reed; A J Shorthouse; J B Anderson
Journal:  Br J Urol       Date:  1995-12

Review 10.  Potency, cure, and local control in the operative treatment of rectal cancer.

Authors:  W E Enker
Journal:  Arch Surg       Date:  1992-12
View more
  8 in total

1.  Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial report.

Authors:  Meijin Huang; Jinxin Lin; Xihu Yu; Shen Chen; Liang Kang; Yanhong Deng; Jian Zheng; Yanxin Luo; Lei Wang; Ping Lan; Jianping Wang
Journal:  Int J Colorectal Dis       Date:  2016-06-06       Impact factor: 2.571

2.  Nerve-oriented mesorectal excision (NOME): autonomic nerves as landmarks for laparoscopic rectal resection.

Authors:  Norbert Runkel; Harald Reiser
Journal:  Int J Colorectal Dis       Date:  2013-05-11       Impact factor: 2.571

3.  The EORTC Quality of Life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients.

Authors:  Juan Ignacio Arraras; Javier Suárez; Fernando Arias de la Vega; Ruth Vera; Gemma Asín; Virginia Arrazubi; Mikel Rico; Lucía Teijeira; Jaione Azparren
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

Review 4.  Sexual dysfunction following rectal cancer surgery.

Authors:  V Celentano; R Cohen; J Warusavitarne; O Faiz; M Chand
Journal:  Int J Colorectal Dis       Date:  2017-05-11       Impact factor: 2.571

5.  A prospective study of sexual and urinary function before and after total mesorectal excision.

Authors:  Audrius Dulskas; Narimantas E Samalavicius
Journal:  Int J Colorectal Dis       Date:  2016-03-09       Impact factor: 2.571

6.  Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.

Authors:  Florian Sterzing; Frieder Hoehle; Alexis Ulrich; Alexandra Jensen; Jürgen Debus; Marc Muenter
Journal:  J Radiat Res       Date:  2014-10-23       Impact factor: 2.724

Review 7.  Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery.

Authors:  A G K McNair; R N Whistance; R O Forsythe; J Rees; J E Jones; A M Pullyblank; K N L Avery; S T Brookes; M G Thomas; P A Sylvester; A Russell; A Oliver; D Morton; R Kennedy; D G Jayne; R Huxtable; R Hackett; S J Dutton; M G Coleman; M Card; J Brown; J M Blazeby
Journal:  Colorectal Dis       Date:  2015-11       Impact factor: 3.788

8.  Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer.

Authors:  Jin-Bo Lin; Lei Zhang; Dong-Wen Wu; Zhou-Huan Xi; Xue-Jun Wang; Yun-Shou Lin; Wakana Fujiwara; Jing-Ru Tian; Min Wang; Peng Peng; Ai Guo; Zhen Yang; Le Luo; Ling-Ya Jiang; Qia-Qia Li; Xue-Ying Zhang; Yun-Feng Zhang; Hou-Wei Xu; Bing Yang; Xun-Lin Li; Yi-Xiong Lei
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.